[7] [9] These contraindications are based on known metabolic pathways, clinical case reports, and established pharmacological principles, and are supported by clinical guidelines and expert consensus
However, its always best to talk to a doctor about health concerns before getting an injection
Researchers, particularly those engaged in Metabolic & Weight Research or even Mitochondrial Research initiatives, are increasingly exploring its potential
Physician Consultation Recommendations: Any individual with chronic health conditions, taking prescription medications, or managing diagnosed medical issues should disclose BPC-157 use to their healthcare provider
Further, patients should be informed that, given the chronic nature of IC/BPS, the typical course involves symptom exacerbations and remissions
Small intestine conditions such as celiac disease, Crohns disease, parasite or bacterial growth